- Home
- MDBH vs ERNA Comparison
MDBH vs ERNA Comparison
Compare MDBH & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDBH
- ERNA
- Stock Information
- Founded
- MDBH 1997
- ERNA 2018
- Country
- MDBH United States
- ERNA United States
- Employees
- MDBH N/A
- ERNA N/A
- Industry
- MDBH
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- MDBH
- ERNA Health Care
- Exchange
- MDBH Nasdaq
- ERNA Nasdaq
- Market Cap
- MDBH 66.8M
- ERNA 56.4M
- IPO Year
- MDBH 2023
- ERNA N/A
- Fundamental
- Price
- MDBH $6.24
- ERNA $0.58
- Analyst Decision
- MDBH
- ERNA
- Analyst Count
- MDBH 0
- ERNA 0
- Target Price
- MDBH N/A
- ERNA N/A
- AVG Volume (30 Days)
- MDBH 12.9K
- ERNA 31.4M
- Earning Date
- MDBH 11-12-2024
- ERNA 03-13-2025
- Dividend Yield
- MDBH N/A
- ERNA N/A
- EPS Growth
- MDBH N/A
- ERNA N/A
- EPS
- MDBH N/A
- ERNA N/A
- Revenue
- MDBH $1,937,885.00
- ERNA $598,000.00
- Revenue This Year
- MDBH N/A
- ERNA N/A
- Revenue Next Year
- MDBH N/A
- ERNA N/A
- P/E Ratio
- MDBH N/A
- ERNA N/A
- Revenue Growth
- MDBH N/A
- ERNA 1072.55
- 52 Week Low
- MDBH $5.78
- ERNA $0.22
- 52 Week High
- MDBH $13.25
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- MDBH 46.63
- ERNA 65.35
- Support Level
- MDBH $6.12
- ERNA $0.38
- Resistance Level
- MDBH $6.31
- ERNA $0.74
- Average True Range (ATR)
- MDBH 0.32
- ERNA 0.12
- MACD
- MDBH 0.00
- ERNA 0.04
- Stochastic Oscillator
- MDBH 37.07
- ERNA 45.81
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.